In this first clinical study to date of an intranasal formulation of ketamine for treatment resistant depression, antidepressant effect was rapid in onset after 1 week of treatment and dose related, finds new double-blind, doubly randomized, delayed-start, placebo-controlled study.

In this first clinical study to date of an intranasal formulation of ketamine for treatment resistant depression, antidepressant effect was rapid in onset after 1 week of treatment and dose related, finds new double-blind, doubly randomized, delayed-start, placebo-controlled study.: http://ift.tt/2Cb138V Read more... http://ift.tt/2CKplqT